Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

Solan: The working of the Drug Control Administration (DCA), Baddi, has come under the scanner as despite large-scale sale of psychotropic drugs in the last one year, the management of Biogenetic Drugs Private Limited failed to disclose details of the buyers to the authorities, violating the conditions of the grant of licence.

The state DCA yesterday froze raw material of psychotropic drugs found at the company premises for its failure to disclose details of the sale of such drugs in around a year.

Information on the stock of raw material as well as psychotropic drugs like alprazolam and codeine found at the premises revealed that the company had been mostly producing only these drugs. Since these drugs are mainly misused by drug abusers, their large-scale production — running into crores of tablets per year — has put a question mark over the operations of this unit, which has been operational since 2005.

Had the Punjab’s Special Task Force not exposed the sales record, it’s debatable whether the SDA would have been able to get a sniff into such suspicious activities.

The company has been issued a three-day notice to disclose its sales record, and its laxity could attract cancellation of its product approval, said State Drugs Controller Manish Kapoor.

According to the probing authorities, the company management is supposed to provide details of the quantity of drugs dispatched, address of purchaser, batch number as well as the sales amount to the drug inspector, state drugs controller and the Superintendent of Police at the time the drugs are dispatched from the company premises.

Sources say that the company had manufactured 21.66 crore alprazolam 0.5 tablets, under various brands, since May 6, 2023.

They had purchased 139 kg of alprazolam as raw material since May 2023, while 40 kg was the stock in hand. It was taken into possession by the Punjab STF under provisions of the Narcotic Drugs and Psychotropic Substances Act.

Apart from this, more than 400 kg of codeine raw material was found on the premises. Alprazolam tablets numbering 1.97 crore were stocked at the manufacturing unit.

“The stock of psychotropic drugs and its raw material like codeine, alprazolam, etc, found on the company premises has been frozen as long as the departmental probe is underway. The management has been issued a three-day notice to respond to the queries regarding the issues raised by the STF, apart from other violations of the non-disclosure of drug sales,” informed Manish Kapoor.

Related Posts

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

According to the US FDA’s latest enforcement report, the recall was initiated after black spots were found on the tablets due to burnt excipient used for manufacturing. New Delhi: Sun…

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

New Delhi: The Delhi Police Crime Branch has busted an alleged illegal network involved in the smuggling, adulteration and distribution of counterfeit and unauthorised anti-cancer and other life-saving medicines in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Meiji Seika to push new vaccine with SII in India

Meiji Seika to push new vaccine with SII in India

DGFT automates EO extension process to ease compliance for pharma exporters

DGFT automates EO extension process to ease compliance for pharma exporters

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark